Clinical implications of QRS duration in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction.
Wang NC, Maggioni AP, Konstam MA, Zannad F, Krasa HB, Burnett JC Jr, Grinfeld L, Swedberg K, Udelson JE, Cook T, Traver B, Zimmer C, Orlandi C, Gheorghiade M; Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators.
Wang NC, et al. Among authors: gheorghiade m.
JAMA. 2008 Jun 11;299(22):2656-66. doi: 10.1001/jama.299.22.2656.
JAMA. 2008.
PMID: 18544725